financetom
Business
financetom
/
Business
/
Recursion Pharmaceuticals Insider Sold Shares Worth $287,200, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Recursion Pharmaceuticals Insider Sold Shares Worth $287,200, According to a Recent SEC Filing
Jan 13, 2025 3:13 PM

05:45 PM EST, 01/13/2025 (MT Newswires) -- Christopher Gibson, Director, Chief Executive Officer, on January 08, 2025, sold 40,000 shares in Recursion Pharmaceuticals ( RXRX ) for $287,200. Following the Form 4 filing with the SEC, Gibson has control over a total of 736,633 shares of the company, with 736,633 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1601830/000160183025000010/xslF345X05/wk-form4_1736807155.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Carvana Insider Sold Shares Worth $3,583,155, According to a Recent SEC Filing
Carvana Insider Sold Shares Worth $3,583,155, According to a Recent SEC Filing
Sep 22, 2025
04:13 AM EDT, 09/22/2025 (MT Newswires) -- Ernest C. Garcia III, 10% Owner, Director, Chief Executive Officer, on September 18, 2025, sold 9,300 shares in Carvana ( CVNA ) for $3,583,155. Following the Form 4 filing with the SEC, Garcia has control over a total of 1,443,716 Class A common shares of the company, with 921,926 shares held directly and...
Sanofi, Regeneron Say Potential Chronic Spontaneous Urticaria Treatment Recommended for EU Approval
Sanofi, Regeneron Say Potential Chronic Spontaneous Urticaria Treatment Recommended for EU Approval
Sep 22, 2025
04:12 AM EDT, 09/22/2025 (MT Newswires) -- Sanofi ( SNY ) and Regeneron Pharmaceuticals ( REGN ) said Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion recommending the approval of Dupixent in the European Union for the treatment of chronic spontaneous urticaria in adults and adolescents. The recommendation covers patients...
Gitlab Insider Sold Shares Worth $22,385,850, According to a Recent SEC Filing
Gitlab Insider Sold Shares Worth $22,385,850, According to a Recent SEC Filing
Sep 22, 2025
04:14 AM EDT, 09/22/2025 (MT Newswires) -- Matthew Jacobson, Director, on September 17, 2025, sold 443,447 shares in Gitlab ( GTLB ) for $22,385,850. Following the Form 4 filing with the SEC, Jacobson has control over a total of 2,183,808 Class A common shares of the company, with 587,050 shares held directly and 1,596,758 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1653482/000119312525209379/xslF345X05/ownership.xml ...
CCC Intelligent Solutions Holdings Insider Sold Shares Worth $1,438,665, According to a Recent SEC Filing
CCC Intelligent Solutions Holdings Insider Sold Shares Worth $1,438,665, According to a Recent SEC Filing
Sep 22, 2025
04:08 AM EDT, 09/22/2025 (MT Newswires) -- John Page Goodson, Executive Vice President, Chief Product and Technology Officer, on September 17, 2025, sold 150,000 shares in CCC Intelligent Solutions Holdings ( CCCS ) for $1,438,665. Following the Form 4 filing with the SEC, Goodson has control over a total of 157,478 common shares of the company, with 157,478 shares held...
Copyright 2023-2026 - www.financetom.com All Rights Reserved